Subscribe free

Cytoreductive Surgery & Peritoneum ·

Robotic Surgery for Limited Peritoneal Metastatic Gastric Cancer Yields Positive Outcomes

Robotic cytoreduction and HIPEC can improve recovery in gastric cancer patients with limited peritoneal metastasis.

  • 100% complete cytoreduction rate achieved with robotic technique.
  • Median hospital stay was just 5 days, a notable reduction from traditional methods.

Favorable outcomes include less blood loss (median 300 ml) and lower transfusion rates (22.2%).

  • Major morbidity was 38.9% and readmission rate was 27.8%, consistent with literature on open surgery.

Journal Article by Buckarma E, Steadman J (…) Grotz TE et 3 al. in Ann Surg Oncol

© 2026. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Cytoreductive Surgery & Peritoneum.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Cytoreductive Surgery & Peritoneum

The latest stitches

Ann Surg Oncol28 Aug 2026

Prophylactic HIPEC Improves Survival in Advanced Colorectal Cancer

Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) significantly enhances peritoneal metastasis-free survival and disease-free survival in patients with locally advanced colorectal cancer, though overall survival rates and complication rates remain unchanged.

All papers in Cytoreductive Surgery & Peritoneum →